Maria Carrillo, Ph.D.
Chief Science Officer, Alzheimer's Association
Dr. Carrillo is Chief Science Officer, Medical and Scientific Relations, at the Alzheimer's Association. At the Association, Dr. Carrillo has a wide range of responsibilities, including oversight of the Association's granting process and communication of scientific findings within and outside of the organization. Dr. Carrillo is responsible for overseeing the international science division for the Alzheimer’s Association and is responsible for sharing the global landscape of research and ongoing investigations with a wide range of constituents.
Dr. Carrillo also manages several Association initiatives. One of these is the Alzheimer's Association International Conference, the largest international discussion on Alzheimer’s and related dementias in the world. Another is the Alzheimer’s Association Research Roundtable, which provides a forum for pharmaceutical companies to discuss trends in Alzheimer research and therapeutic targets. Other Association programs managed by Dr. Carrillo include the management of the World-Wide Alzheimer’s Disease Neuroimaging Initiative (WW-ADNI), which is a multi-country research effort aimed at finding biomarkers for early detection of Alzheimer’s, Dr. Carrillo is a member of the Genworth Financial Medical Advisory Board and an Advisory Committee member for The Shriver Report, and co-editor of Modernizing the Diagnosis of Alzheimer’s Disease.
Dr. Carrillo is also co-author of the NIA-AA revised criteria, and Appropriate Use Criteria for
Amyloid Imaging. Dr Carrillo is on the Advisory Committee for the World Health Organization Dementia Setting Priorities & Portfolio Analysis. Dr. Carrillo leads the GAAIN effort which aims to create a federated network to support all publicly accessible data in dementia, and works with the
OECD on Big Data Solutions for Global Dementia Research. Dr. Carrillo has published extensively
in the area of Alzheimer’s disease on early diagnosis and biomarker standardization efforts, in addition to global challenges to progress for research in Alzheimer’s and dementia.
Dr. Carrillo received her Ph.D. from Northwestern University’s Institute for Neuroscience in 1996.
Since graduating from Northwestern, she completed a postdoctoral fellowship in the Division of Neurological Sciences at Rush University Medical Center in Chicago, where she later took a position as an assistant professor.
Dr. Carrillo also manages several Association initiatives. One of these is the Alzheimer's Association International Conference, the largest international discussion on Alzheimer’s and related dementias in the world. Another is the Alzheimer’s Association Research Roundtable, which provides a forum for pharmaceutical companies to discuss trends in Alzheimer research and therapeutic targets. Other Association programs managed by Dr. Carrillo include the management of the World-Wide Alzheimer’s Disease Neuroimaging Initiative (WW-ADNI), which is a multi-country research effort aimed at finding biomarkers for early detection of Alzheimer’s, Dr. Carrillo is a member of the Genworth Financial Medical Advisory Board and an Advisory Committee member for The Shriver Report, and co-editor of Modernizing the Diagnosis of Alzheimer’s Disease.
Dr. Carrillo is also co-author of the NIA-AA revised criteria, and Appropriate Use Criteria for
Amyloid Imaging. Dr Carrillo is on the Advisory Committee for the World Health Organization Dementia Setting Priorities & Portfolio Analysis. Dr. Carrillo leads the GAAIN effort which aims to create a federated network to support all publicly accessible data in dementia, and works with the
OECD on Big Data Solutions for Global Dementia Research. Dr. Carrillo has published extensively
in the area of Alzheimer’s disease on early diagnosis and biomarker standardization efforts, in addition to global challenges to progress for research in Alzheimer’s and dementia.
Dr. Carrillo received her Ph.D. from Northwestern University’s Institute for Neuroscience in 1996.
Since graduating from Northwestern, she completed a postdoctoral fellowship in the Division of Neurological Sciences at Rush University Medical Center in Chicago, where she later took a position as an assistant professor.
Recent Posts
| NIH launches of All of Us Research Program |
| May 30, 2018 |
| New Biological Research Framework for Alzheimer’s Released |
| April 10, 2018 |
| IDEAS Study Reaches Recruitment Goal, Demonstrates Value of PET Scans |
| December 13, 2017 |
